BYU researchers develop MOTO-CAR macrophage therapy to target solid tumors in preclinical study
Preclinical research demonstrates that macrophages can be programmed to fight solid cancer tumors, offering a potential new immunotherapy approach. The development comes as cancer kills one person every 50 seconds in the U.S., with some cancers continuing to resist current treatments.
